First in Human Safety and Ease of Use Assessment of 400mg Progesterone Callavid in Women With Luteal Phase Insufficiency

NCT07136922 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Luteal Phase Insuffiency
Progesterone Delivery

Interventions

COMBINATION_PRODUCT: 400mg progesterone Callavid - 2hr wear
DRUG: Cyclogest 400 mg
COMBINATION_PRODUCT: 400mg progesterone Callavid - 3hr wear

Sponsor

Calla Lily Clinical Care Ltd

Collaborators

[object Object]
[object Object]